UNSPSC 85812103: Introduction of analgesics, hypnotics, sedatives into eye, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of analgesics, hypnotics, sedatives into eye, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0C3NZ

UNSPSC 85812103, Introduction of analgesics, hypnotics, sedatives into eye, percutaneous approach, is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement activity. The recent opportunities tagged to this code span telehealth delivery, occupational health services, cancer screening, inmate healthcare, employee wellness programs, and opioid use disorder treatment—none of which involve pharmaceutical injection into the eye. State and local buyers are not procuring this service under this code at present.

The mismatch between the code's nominal scope and recent solicitations suggests either systematic miscoding by issuing bodies or that this Commodity code sees minimal recent state and local procurement activity. The opportunities in the dataset—including virtual urgent care from Inland Empire Health Plan (California, RFI due October 31, 2026), medical services from DeKalb County (Georgia, RFP due November 12, 2026), PACE operations from Nevada Health Authority (RFP due December 10, 2026), and employee wellness portals, cancer screening, and occupational health from county and municipal health systems across California, Colorado, Kansas, and Florida—share no common thread with ophthalmic pharmaceutical administration. This code should be considered inactive or misapplied for state and local procurement planning purposes.